The American Thyroid Association and American Association of Clinical Endocrinologists Hyperthyroidism and Other Causes of Thyrotoxicosis guidelines: Viewpoints from Japan and Korea

Thyroid

Volumn 21, Issue 6, 2011, Pages 577-580

  Yamashita, Shunichi ^a,b   Amino, Nobuyuki ^c,d   Shong, Young Kee ^a,e  

^a Oceania Thyroid Association (AOTA)   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c World Thyroid Foundation   (Japan)

^d KUMA HOSPITAL   (Japan)

^e University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE; LEVOTHYROXINE; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN RECEPTOR ANTIBODY;

ASIAN; COST EFFECTIVENESS ANALYSIS; DIETARY INTAKE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; JAPAN; KOREA; MEDICAL SOCIETY; PATHOGENESIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RADIOISOTOPE THERAPY; REVIEW; THYROTOXICOSIS;

ANTITHYROID AGENTS; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; JAPAN; PRACTICE GUIDELINES AS TOPIC; REPUBLIC OF KOREA; THYROID HORMONES; THYROTOXICOSIS;

EID: 79958784485     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.2106.ed1     Document Type: Review

References (20)

1. ATA/AACE Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis; Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21:593-646.
2. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M 1991 Differences and similarities in the diagnosis and treatment of Graves disease in Europe, Japan and the United States. Thyroid 1:129-135.
3. Nakamura H 2006 Guideline for treatment of Graves disease with antithyroid drugs in Japan. Nippon Rinsho 64:2243-2249. In Japanese.
4. Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A 2009 Methimazole-induced agranulocytosis in patients with Graves disease is more frequent with an initial dose of 30mg daily than with 15mg daily. Thyroid 19:559-563.
5. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N 2007 Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves disease. J Clin Endocrinol Metab 92:2157-2162. (Pubitemid 46997115)
6. Orito Y, Oku H, Kubota S, Amino N, Shimogaki K, Hata M, Manki K, Tanaka Y, Sugino S, Ueta M, Kawakita K, Nunotani T, Tatsumi N, Ichihara K, Miyauchi A, Miyake M 2009 Thyroid function in early pregnancy in Japanese healthy women: relation to urinary iodine excretion, emesis, and fetal and child development. J Clin Endocrinol Metab 94:1683-1688.
7. Yoshimura Noh J, Miyazaki N, Ito K, Takeda K, Hiramatsu S, Morita S, Miyauchi A, Murakami T, Inomata K, Noguchi S, Satoh T, Amino N 2008 Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid 18:1157-1164.
8. Ota H, Amino N, Morita S, Kobayashi K, Kubota S, Fukata S, Kamiyama N, Miyauchi A 2007 Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves disease. Clin Endocrinol (Oxf) 67:41-45. (Pubitemid 46955437)
9. Nishihara E, Chen CR, Higashiyama T, Mizutori-Sasai Y, Ito M, Kubota S, Amino N, Miyauchi A, Rapoport B 2010 Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity. Thyroid 20:1307-1314.
10. Amino N, Hidaka Y, Takano T, Tatsumi KI, Izumi Y, Nakata Y 2003 Possible induction of Graves disease and painless thyroiditis by gonadotropin-releasing hormone analogues. Thyroid 13:815-818. (Pubitemid 37070161)
11. Warfofsky L 1973 Low remission rate after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results. JAMA 26:1083-1088.
12. Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE 1993 Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves hyperthyroidism. J Clin Endocrinol Metab 76:928-932. (Pubitemid 23110840)
13. Dai WX, Lian XI, Li SH, Li XW 2006 Effect of universal salt iodination on antithyroid drugs. Chin Med J 119:1108-1112.
14. Abraham P, Avenell A, McGreoch SC, Clark LF, Beva JS 2010 Antithyroid drug regimen for treating Graves hyperthyroidism (Review). Cochrane Database Syst Rev 2010: CD003420.
15. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T 1991 Administration of thyroxine in treated Graves disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 324:947-953.
16. Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK 1992 Evaluation of serum basal thyrotropin levels and thyrotropin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves disease. Clin Endocrinol 36:585-590.
17. Konishi T, Okamoto Y, Ueda M, Fukuda Y, Harusato I, Tsukamoto Y, Hamada N 2011 Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves disease; a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission. Endocr J 58:95-100.
18. Mazza E, Carlini M, Flecchia A, Blatto A, Zuccarini O, Gamba S, Beninati S, Messina M 2008 Long-term follow-up of patients with hyperthyroidism due to Graves disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study. J Endocrinol Invest 31:866-872.
19. Feldt-Rasmussen U, Schleusener H, Carayon P 1994 Metaanalysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves disease. J Clin Endocrinol Metab 78:98-102. (Pubitemid 24026755)
20. Lauberg P, Buchholtz Hansen PE, Iversen E, Eskjaer Jensen S, Weeke J 1986 Goiter size and outcome of medical treatment of Graves disease. Acta Endocrinol (Copenh) 111: 39-43. (Pubitemid 16187044)